BioLife Solutions, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
BioLife Solutions, Inc. (BLFS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $1.91 per share for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-09.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2018-03-09
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2017-03-31 was $1.13, a 12.40% decline year-over-year.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2016-09-30 was $1.32, a 30.53% decline year-over-year.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2016-06-30 was $1.24, a 29.14% decline year-over-year.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2016-03-31 was $1.29.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2017 was $1.91, a 51.59% increase from fiscal 2016.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2016 was $1.26, a 28.00% decline from fiscal 2015.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2015 was $1.75.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2017-12-31 | $1.91 10-K · filed 2018-03-09 | |||
| 2017-09-30 | $1.13 10-Q · filed 2017-11-09 | |||
| 2017-06-30 | $1.13 10-Q · filed 2017-08-11 | |||
| 2017-03-31 | $1.13 10-Q · filed 2017-05-12 | |||
| 2016-12-31 | $1.26 10-K · filed 2018-03-09 | |||
| 2016-09-30 | $1.32 10-Q · filed 2017-11-09 | $1.26 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | $1.24 10-Q · filed 2017-08-11 | $1.25 10-Q · filed 2017-08-11 | ||
| 2016-03-31 | $1.29 10-Q · filed 2017-05-12 | |||
| 2015-12-31 | $1.75 10-K · filed 2017-03-15 | |||
| 2015-09-30 | $1.90 10-Q · filed 2016-11-10 | $1.75 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | $1.75 10-Q · filed 2016-08-11 | $1.75 10-Q · filed 2016-08-11 | ||
| 2013-03-31 | $0.08 10-Q · filed 2013-05-14 | |||
| 2012-06-30 | $0.07 10-Q · filed 2013-08-12 | $0.07 10-Q · filed 2013-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |